AGP Executive Report
Last update: 13 minutes agoNuclear Safety Push: President Tokayev met IAEA chief Rafael Grossi, backing a roadmap to deepen Kazakhstan–IAEA cooperation through 2036 and new steps in nuclear medicine and science, as the country strengthens ties on safety and disarmament. Healthcare Industry Moves: Kazakhstan approved a $71m (32.5 bln tenge) full-cycle biopharmaceutical plant in the Alatau SEZ, aiming to localize production of 20 medicine types (including cancer and rare-disease treatments) with construction through 2031 and full capacity later. Pharma Access Reform: Kazakhstan is preparing faster medicine import approvals for drugs already cleared by the FDA and EMA, with authorization potentially in as little as 15 days. Public Health Updates: East Kazakhstan recorded tick-borne encephalitis and Lyme disease cases; meanwhile, HPV vaccination continues in the north, with school-based delivery and parental consent. Regional Context: Putin’s high-level state visit to Astana is set to include documents spanning energy, finance—and healthcare—signaling deeper bilateral cooperation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
